These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15765769)

  • 21. [Is the successful eradication of Helicobacter pylori sufficient for the healing of peptic ulcer?].
    Pregun I; Herszényi L; Juhász M; Miheller P; Tulassay Z
    Orv Hetil; 2006 Mar; 147(10):435-9. PubMed ID: 16573172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of proton pump inhibitors in the management of upper gastrointestinal bleeding.
    Leontiadis GI; Howden CW
    Gastroenterol Clin North Am; 2009 Jun; 38(2):199-213. PubMed ID: 19446254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cost-effectiveness of high-dose oral proton pump inhibition after endoscopy in the acute treatment of peptic ulcer bleeding.
    Barkun AN; Herba K; Adam V; Kennedy W; Fallone CA; Bardou M
    Aliment Pharmacol Ther; 2004 Jul; 20(2):195-202. PubMed ID: 15233700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton-pump inhibitors and outcome of endoscopic hemostasis in bleeding peptic ulcers: a series of meta-analyses.
    Andriulli A; Annese V; Caruso N; Pilotto A; Accadia L; Niro AG; Quitadamo M; Merla A; Fiorella S; Leandro G
    Am J Gastroenterol; 2005 Jan; 100(1):207-19. PubMed ID: 15654802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Helicobacter pylori infection and NSAIDs on the risk of peptic ulcer bleeding.
    Mahachai V; Thomson AB; Vilaichone RK
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S295-9. PubMed ID: 16083206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnosis and treatment of bleeding peptic ulcer: our experience].
    Zippi M; Febbraro I; De Felici I; Mattei E; Traversa G; Occhigrossi G
    Clin Ter; 2008; 159(4):249-55. PubMed ID: 18776982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Proton pump inhibitors in bleeding stomach ulcer?].
    Schaffalitzky de Muckadell OB
    Ugeskr Laeger; 2006 Mar; 168(10):1024-6. PubMed ID: 16522294
    [No Abstract]   [Full Text] [Related]  

  • 29. Recent advances in proton pump inhibitors and management of acid-peptic disorders.
    Jain KS; Shah AK; Bariwal J; Shelke SM; Kale AP; Jagtap JR; Bhosale AV
    Bioorg Med Chem; 2007 Feb; 15(3):1181-205. PubMed ID: 17150362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
    Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
    Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Somatostatin and its analogues in peptic ulcer bleeding: facts and pathophysiological aspects.
    Sgouros SN; Bergele C; Viazis N; Avgerinos A
    Dig Liver Dis; 2006 Feb; 38(2):143-8. PubMed ID: 16005698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cost-effectiveness and budget impact of intravenous versus oral proton pump inhibitors in peptic ulcer hemorrhage.
    Spiegel BM; Dulai GS; Lim BS; Mann N; Kanwal F; Gralnek IM
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):988-997. PubMed ID: 16844422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
    Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD
    J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease.
    Take S; Mizuno M; Ishiki K; Nagahara Y; Yoshida T; Yokota K; Oguma K; Okada H; Shiratori Y
    Am J Gastroenterol; 2005 May; 100(5):1037-42. PubMed ID: 15842576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of acute upper gastrointestinal bleeding.
    van Leerdam ME
    Best Pract Res Clin Gastroenterol; 2008; 22(2):209-24. PubMed ID: 18346679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients.
    Giral A; Celikel CA; Ozdogan O; Tözün N; Ulusoy NB; Kalayci C
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1886-91. PubMed ID: 16336449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of bleeding gastroduodenal ulcer].
    Adamsen S; de Muckadell OB
    Ugeskr Laeger; 2007 Apr; 169(17):1551-5. PubMed ID: 17484823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gastroenterology in family practice. Updates for your "stomach patient"].
    Stiefelhagen P
    MMW Fortschr Med; 2006 Jun; 148(22):4-6. PubMed ID: 16821566
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical practice and evidence in endoscopic treatment of bleeding peptic gastroduodenal ulcer.
    Adamsen S; Bendix J; Kallehave F; Moesgaard F; Nilsson T; Wille-Jørgensen P
    Scand J Gastroenterol; 2007 Mar; 42(3):318-23. PubMed ID: 17354110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergency gastric ulcer complications in elderly. Factors affecting the morbidity and mortality in relation to therapeutic approaches.
    Di Carlo I; Toro A; Sparatore F; Primo S; Barbagallo F; Di Blasi M
    Minerva Chir; 2006 Aug; 61(4):325-32. PubMed ID: 17122765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.